To investigate whether treatment with targeted IFN fusion proteins can enhance tumor antigen-specific T cell killing activity, we generated chicken ovalbumin over-expressing cell lines (LL/2-OVA and MC38-OVA), and evaluated antigen-specific T cell killing using CellTiter Glo assays. Here, IFNA1 is linked to neoplasm.